| JAMA Dermatology | JAMA Dermatology | 272 days | save |  |  |  |
| Errors in the Abstract, Introduction, Methods, and Discussion Sections | JAMA Dermatology | 272 days | save | | | |
| Spectrum of Nail Sequelae in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis | JAMA Dermatology | 272 days | save | | | |
| Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis | JAMA Dermatology | 272 days | save | | | |
| Reddish-Brown Hematomalike Annular Plaque in a Healthy Patient’s Axilla | JAMA Dermatology | 272 days | save | | | |
| Association Between Early Severe Cardiovascular Events and Ustekinumab Treatment?—Reply | JAMA Dermatology | 272 days | save | | | |
| Association Between Early Severe Cardiovascular Events and Ustekinumab Treatment? | JAMA Dermatology | 272 days | save | | | |
| Telemedicine Triage Initiative for Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis | JAMA Dermatology | 272 days | save | | | |
| Cost Minimization Analysis of a Teledermatology Triage System in a Managed Care Setting | JAMA Dermatology | 272 days | save | | | |
| Pain Severity and Management of Hidradenitis Suppurativa at US Emergency Department Visits | JAMA Dermatology | 272 days | save | | | |
| Erythema Ab Igne | JAMA Dermatology | 272 days | save | | | |
| Economics of Teledermatology | JAMA Dermatology | 272 days | save | | | |
| Transposed Author Names | JAMA Dermatology | 272 days | save | | | |
| Suicidality and Psychological Adverse Events in Patients Treated With Finasteride | JAMA Dermatology | 272 days | save | | | |
| Use of Topical Sirolimus (Rapamycin) for Treating Confluent and Reticulated Papillomatosis | JAMA Dermatology | 272 days | save | | | |
| Diagnosis, Clinical Features, and Management of Patients With Granulomatous Cheilitis | JAMA Dermatology | 272 days | save | | | |
| Ongoing Concerns Regarding Finasteride for the Treatment of Male-Pattern Androgenetic Alopecia | JAMA Dermatology | 272 days | save | | | |
| Consensus Statement for Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome | JAMA Dermatology | 272 days | save | | | |
| Rapid Stiffness and Nodularity of Both Hands in a Middle-aged Woman | JAMA Dermatology | 272 days | save | | | |
| Trends in Merkel Cell Carcinoma Incidence in the United States | JAMA Dermatology | 272 days | save | | | |
| Trichodysplasia Spinulosa in a Kidney Transplant Recipient | JAMA Dermatology | 272 days | save | | | |
| Low-Dose Total Skin Electron Beam Therapy for Treatment of Sézary Syndrome | JAMA Dermatology | 272 days | save | | | |
| Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Melanoma | JAMA Dermatology | 272 days | save | | | |
| Fibroblast Growth Factor Receptor Inhibitors and Nonuremic Calciphylaxis | JAMA Dermatology | 272 days | save | | | |
| Secukinumab and Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis | JAMA Dermatology | 272 days | save | | | |
| Tofacitinib for Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome | JAMA Dermatology | 272 days | save | | | |
| New Primary Melanoma After Treatment With Immune Checkpoint Inhibitors | JAMA Dermatology | 272 days | save | | | |
| JAMA Dermatology | JAMA Dermatology | 314 days | save | | | |
| Sebaceous Carcinoma Incidence and Survival in Solid Organ Transplant Recipients | JAMA Dermatology | 314 days | save | | | |
| Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy—Reply | JAMA Dermatology | 314 days | save | | | |
| Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy | JAMA Dermatology | 314 days | save | | | |
| Multiple vs First Incidence of Cutaneous Squamous Cell Carcinoma and Estimation of Future Incidences | JAMA Dermatology | 314 days | save | | | |
| Underestimation of Cutaneous Squamous Cell Carcinoma Incidence in Cancer Registries | JAMA Dermatology | 314 days | save | | | |
| Generalized Pruriginous Eruption on a Patient With Leukemia | JAMA Dermatology | 314 days | save | | | |
| Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis | JAMA Dermatology | 314 days | save | | | |
| Improving Outcomes for Patients With Epidermal Necrolysis | JAMA Dermatology | 314 days | save | | | |
| Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis | JAMA Dermatology | 314 days | save | | | |
| Papuloerythroderma of Ofuji | JAMA Dermatology | 314 days | save | | | |
| Contribution of Genetics to the Susceptibility to Hidradenitis Suppurativa | JAMA Dermatology | 314 days | save | | | |
| Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Australia | JAMA Dermatology | 314 days | save | | | |
| Prevalence of Dermatitis Herpetiformis Within the iCureCeliac Patient-Powered Research Network | JAMA Dermatology | 314 days | save | | | |
| A Solitary Lump on the Scalp | JAMA Dermatology | 314 days | save | | | |
| Baricitinib Combined With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis | JAMA Dermatology | 314 days | save | | | |
| Ventriculoperitoneal Shunt Infection | JAMA Dermatology | 314 days | save | | | |
| Cellulitis | JAMA Dermatology | 314 days | save | | | |
| Safety and Efficacy of VP-102 in Children and Adults With Molluscum Contagiosum | JAMA Dermatology | 314 days | save | | | |
| Characterizing Disease Features and Other Medical Diagnoses in Patients With Pityriasis Rubra Pilaris | JAMA Dermatology | 314 days | save | | | |
| Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus | JAMA Dermatology | 314 days | save | | | |
| TEMPI Syndrome With Progressive Telangiectasias Associated With Pulmonary Deterioration | JAMA Dermatology | 314 days | save | | | |
| Early Features of Progressive Hemifacial Atrophy | JAMA Dermatology | 314 days | save | | | |
| | 
report | next » |
| |
